Paul E. Zarek

Array ( [id] => 5452327 [patent_doc_number] => 20090068364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Method of surface treatment using imidazole compound' [patent_app_type] => utility [patent_app_number] => 12/290328 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2135 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068364.pdf [firstpage_image] =>[orig_patent_app_number] => 12290328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576062 [patent_doc_number] => 20090143424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'TETRAKIS-QUATERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACTEYLCHOLINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/260502 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15606 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143424.pdf [firstpage_image] =>[orig_patent_app_number] => 12260502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4480 [patent_doc_number] => 07816391 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Chemical compounds' [patent_app_type] => utility [patent_app_number] => 12/259562 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44810 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816391.pdf [firstpage_image] =>[orig_patent_app_number] => 12259562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690027 [patent_doc_number] => 08389555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Medicaments' [patent_app_type] => utility [patent_app_number] => 12/740147 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 22 [patent_no_of_words] => 35343 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413692 [patent_doc_number] => 08697730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => '5-lipoxygenase activating protein (FLAP) inhibitor' [patent_app_type] => utility [patent_app_number] => 12/257876 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 60403 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12257876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545299 [patent_doc_number] => 20090155176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Compositions and methods for treatment of diabetic retinopathy' [patent_app_type] => utility [patent_app_number] => 12/288330 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 40051 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155176.pdf [firstpage_image] =>[orig_patent_app_number] => 12288330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331350 [patent_doc_number] => 20090111827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'ARYLINDENOPYRIMIDINES COMPOUND AND USE AS AN ADENOSINE A2a RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/253358 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3970 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111827.pdf [firstpage_image] =>[orig_patent_app_number] => 12253358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379449 [patent_doc_number] => 20090191288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases' [patent_app_type] => utility [patent_app_number] => 12/248402 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33925 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191288.pdf [firstpage_image] =>[orig_patent_app_number] => 12248402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375911 [patent_doc_number] => 20100076069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'FORSKOLIN DOSING REGIMEN IN OPEN ANGLE GLAUCOMA AND PATIENT COMPLIANCE METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/235222 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2205 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076069.pdf [firstpage_image] =>[orig_patent_app_number] => 12235222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509159 [patent_doc_number] => 20090082366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'DEUTERIUM-ENRICHED TELAPREVIR' [patent_app_type] => utility [patent_app_number] => 12/233655 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3854 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082366.pdf [firstpage_image] =>[orig_patent_app_number] => 12233655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509207 [patent_doc_number] => 20090082414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'DEUTERIUM-ENRICHED VIRAMIDINE' [patent_app_type] => utility [patent_app_number] => 12/233645 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3005 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082414.pdf [firstpage_image] =>[orig_patent_app_number] => 12233645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421841 [patent_doc_number] => 08278328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Compounds which have activity at M1 receptor and their uses in medicine' [patent_app_type] => utility [patent_app_number] => 12/678347 [patent_app_country] => US [patent_app_date] => 2008-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65177 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102706 [patent_doc_number] => 07723337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => '3-cinnolinecarboxamide derivatives and their use for treating cancer' [patent_app_type] => utility [patent_app_number] => 12/210588 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25161 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723337.pdf [firstpage_image] =>[orig_patent_app_number] => 12210588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355553 [patent_doc_number] => 20090186897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'PHTHALAZINONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/209400 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15680 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186897.pdf [firstpage_image] =>[orig_patent_app_number] => 12209400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214220 [patent_doc_number] => 20110136825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Treatment of Vasomotor Symptoms' [patent_app_type] => utility [patent_app_number] => 12/675231 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2709 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136825.pdf [firstpage_image] =>[orig_patent_app_number] => 12675231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988061 [patent_doc_number] => 08076325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => '1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 12/283110 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24657 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076325.pdf [firstpage_image] =>[orig_patent_app_number] => 12283110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026612 [patent_doc_number] => 08536194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Pyrazolopyridine derivates' [patent_app_type] => utility [patent_app_number] => 12/206289 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53830 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12206289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432229 [patent_doc_number] => 07968561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Steroidal compounds as steroid sulphatase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/200252 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27695 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968561.pdf [firstpage_image] =>[orig_patent_app_number] => 12200252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515495 [patent_doc_number] => 20090215802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'DEUTERIUM-ENRICHED LAPATINIB' [patent_app_type] => utility [patent_app_number] => 12/196653 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3861 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215802.pdf [firstpage_image] =>[orig_patent_app_number] => 12196653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296176 [patent_doc_number] => 20100240605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'NOVEL IMMUNOTHERAPY STRATEGY' [patent_app_type] => utility [patent_app_number] => 12/670520 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8132 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240605.pdf [firstpage_image] =>[orig_patent_app_number] => 12670520 [rel_patent_id] =>[rel_patent_doc_number] =>)